we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other best growth stocks under $100 to buy now ...

Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

Deep-pocketed investors have adopted a bearish approach towards DexCom DXCM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

DexCom's growth is slowing ... According to management, FY25 too should be growing at a growth rate of ~14%. I believe there are significant headwinds in DXCM’s growth path going forward ...

DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost ...

The best way to grow your wealth and better prepare yourself ... which should help to power the continued increase in Stryker's annual dividend. DexCom (NASDAQ: DXCM) is a medical device company ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

SAN DIEGO – DexCom has named Jon Coleman as chief commercial officer to oversee the company’s global commercial organization, including sales, marketing and customer experience.

Growing pains: Dexcom’s manufacturing move to lay off 535 in San Diego Dexcom laid off more than 500 workers in San Diego last summer as it aims to transform its HQ into an R&D-focused center ...

DexCom provides continuous glucose monitoring for diabetics and should enjoy steady growth as the market for diabetes expands. The best way to grow your wealth and better prepare yourself for ...